Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB)

Journal of Neuro-Oncology

Volumn 80, Issue 3, 2006, Pages 285-293

  Bergenheim, A Tommy ^a   Roslin, Michael ^a   Ungerstedt, Urban ^b   Waldenström, Anders ^a   Henriksson, Roger ^a   Ronquist, Gunnar ^c  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diaminobuturic acid; Glioblastoma; Loco regional treatment; Microdialysis

Indexed keywords

2,4 DIAMINOBUTYRIC ACID; ALANINE; ANTINEOPLASTIC AGENT; ASPARTIC ACID; BETAMETHASONE; CARBAMAZEPINE; GLUCOSE; GLUTAMIC ACID; GLYCEROL; GLYCINE; PHENYTOIN; RINGER SOLUTION; SERINE; TAURINE; THREONINE;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN EDEMA; BRAIN METABOLISM; BRAIN RADIATION; BRAIN SURGERY; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS CATHETER; FEASIBILITY STUDY; FEMALE; GLIOBLASTOMA; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; MICRODIALYSIS; PATIENT MOBILITY; SEIZURE;

AGED; AMINOBUTYRIC ACIDS; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; CATHETERS, INDWELLING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLIOBLASTOMA; GLUTAMIC ACID; GLYCEROL; HUMANS; INFUSIONS, INTRALESIONAL; MALE; MICRODIALYSIS; MIDDLE AGED; MONITORING, AMBULATORY; STEREOTAXIC TECHNIQUES; TAURINE; TREATMENT OUTCOME;

EID: 33751243646     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9186-1     Document Type: Article

References (36)

1. Vick NA, Khandekar JD, Bigner DD (1977) Chemotherapy of brain tumors. Arch Neurol 34:523-526
2. Blasberg RG, Groothuis DR (1986) Chemotherapy of brain tumors: physiological and pharmacokinetic considerations. Semin Oncol 13:70-82
3. Donelli MG, Zucchetti M, D'Incalci M (1992) Do anticancer agents reach the tumor target in the human brain? Cancer Chemother Pharmacol 30:251-260
4. Bergenheim AT, Capala J, Roslin M, Henriksson R (2005) Distribution of P-BPA and metabolic assessment in glioblastoma. A microdialysis study in patients during BNCT treatment. J Neurooncol 71:287-293
5. Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30:907-911
6. Brem H, Mahaley MS Jr, Vick NA, Black KL, Schold SC Jr, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW et al (1991) Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74:441-446
7. Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G, Kuurne T (1997) Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study. Neurosurgery 41:44-48 discussion 48-49
8. Brem H, Ewend MG, Piantadosi S, Greenhoot J, Burger PC, Sisti M (1995) The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial. J Neurooncol 26:111-123
9. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345:1008-1012
10. Boiardi A, Silvani A, Pozzi A, Fariselli L, Broggi G, Salmaggi A (1999) Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: Improved survival in sequential studies. J Neurooncol 41:151-157
11. Wakabayashi T, Yoshida J, Mizuno M, Kajita Y (2001) Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma. Brain Tumor Pathol 18:23-28
12. Patchell RA, Regine WF, Ashton P, Tibbs PA, Wilson D, Shappley D, Young B (2002) A phase I trial of continuously infused intratumoral bleomycin for the treatment of recurrent glioblastoma multiforme. J Neurooncol 60:37-42
13. Ungerstedt U, Pycock C (1974) Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss 30:44-55
14. Meyerson BA, Linderoth B, Karlsson H, Ungerstedt U (1990) Microdialysis in the human brain: Extracellular measurements in the thalamus of parkinsonian patients. Life Sci 46:301-308
15. Persson L, Hillered L (1992) Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg 76:72-80
16. Ungerstedt U (1997) Microdialysis - a new technique for monitoring local tissue events in the clinic. Acta Anaesthesiol Scand Suppl 110:123
17. Ronquist G, Hugosson R, Sjolander U, Ungerstedt U (1992) Treatment of malignant glioma by a new therapeutic principle. Acta Neurochir (Wien) 114:8-11
18. Ronquist G, Westermark B, Hugosson R (1984) Induction of complete and irreversible damage to malignant glioma cells by L-2,4 diaminobutyric acid. Anticancer Res 4:225-228
19. Christensen HNDCC, Handlogten ME, Ronquist G (1973) Energization of amino acid transport, studied for the Ehrlich ascites tumor cell. Biochim Biophys Acta 300:487-522
20. Ronquist G, Agren G, Ponten J, Westermark B (1976) Alpha-aminoisobutyric acid transport into human glia and glioma cells in culture. J Cell Physiol 89:433-439
21. Roslin M, Henriksson R, Bergstrom P, Ungerstedt U, Bergenheim AT (2003) Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol 61:151-160
22. Hariz MI, Bergenheim AT (1990) A comparative study on ventriculographic and computerized tomography-guided determinations of brain targets in functional stereotaxis. J Neurosurg 73:565-571
23. Laitinen LV, Liliequist B, Fagerlund M, Eriksson AT (1985) An adapter for computed tomography-guided stereotaxis. Surg Neurol 23:559-566
24. Lindroth PMK (1979) High performance liquid chromatography determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with orthoptaldialdehyde. Anal Chem 51:1667-1674
25. Reid MS, Herrera-Marschitz M, Kehr J, Ungerstedt U (1990) Striatal dopamine and glutamate release: Effects of intranigral injections of substance P. Acta Physiol Scand 140:527-537
26. Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-270
27. Heacock AM, Kerley D, Gurda GT, VanTroostenberghe AT, Fisher SK (2004) Potentiation of the osmosensitive release of taurine and d-aspartate from SH-SY5Y neuroblastoma cells after activation of M3 muscarinic cholinergic receptors. J Pharmacol Exp Ther 311:1097-1104
28. Ordaz B, Vaca L, Franco R, Pasantes-Morales H (2004) Volume changes and whole cell membrane currents activated during gradual osmolarity decrease in C6 glioma cells: Contribution of two types of K+ channels. Am J Physiol Cell Physiol 286:C1399-C1409
29. Steenbergen C, Hill ML, Jennings RB (1985) Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. Circ Res 57:864-875
30. Song D, O'Regan MH, Phillis JW (1996) Release of the excitotoxic amino acids, glutamate and aspartate, from the isolated ischemic/anoxic rat heart. Neurosci Lett 220:1-4
31. Schaffer SW, Pastukh V, Solodushko V, Kramer J, Azuma J (2002) Effect of ischemia, calcium depletion and repletion, acidosis and hypoxia on cellular taurine content. Amino Acids 23:395-400
32. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M (2001) Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010-1015
33. Fazeny-Dorner B, Wenzel C, Veitl M, Piribauer M, Rossler K, Dieckmann K, Ungersbock K, Marosi C (2003) Survival and prognostic factors of patients with unresectable glioblastoma multiforme. Anticancer Drugs 14:305-312
34. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. J Neurosurg 99:467-473
35. Quigley MR, Flores N, Maroon JC, Sargent B, Lang S, Elrifai A (1995) Value of surgical intervention in the treatment of glioma. Stereotact Funct Neurosurg 65:171-175
36. Kreth FW, Warnke PC, Scheremet R, Ostertag CB (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762-766